MET and glioblastoma: Although MET was cytotoxic at high, clinically not relevant concentrations in all GBM cells, we only observed a weak MET-induced sensitization to doxorubicin in one established cell line and in primary cells, while no effect of MET was observed on TMZ-induced cell death.